structural genomics การใช้

• A " Science " article from January 2006 analyzes the structural genomics field.
• Structural genomics is just one endeavor spawned by completion of the genome project.
• The TB Structural Genomics Consortium, for example, focused exclusively on functionally characterized proteins.
• One goal of structural genomics is to identify novel protein folds.
• This is performed in dedicated centers of structural genomics.
• Still, critics challenge how valuable structural genomics will be.
• The PDB is a key resource in areas of structural biology, such as structural genomics.
• Structural genomics emphasizes high throughput determination of protein structures.
• Structural genomics can be used to predict novel protein folds based on other structural data.
• So doing thousands of structures a year, the goal of structural genomics, will require large-scale automation.
• -- TB Structural Genomics Consortium ( scientists from six countries, including India, Japan, Great Britain, United States)
• Determining a representative tertiary structure for each sequence cluster is the aim of many structural genomics initiatives.
• The completed table would mark the end of structural genomics, the analysis of the structure of genes.
• Structural genomics takes advantage of completed genome sequences in several ways in order to determine protein structures.
• Proponents of structural genomics point out that similar objections were raised at first to the Human Genome Project.
• -- Northeast Structural Genomics Consortium ( researchers from New Jersey, New York, Connecticut, Washington state, and Ontario, Canada)
• -- Joint Center for Structural Genomics ( Stanford Synchrotron Radiation Laboratory, University of California-San Diego, Scripps Research Institute)
• Thus, the high-throughput structure determination methods of structural genomics have the potential to inform our understanding of protein functions.
• Its advocates predict that structural genomics, the science behind it, will be the Rosetta stone for the body's book.
• But no structural genomics company or laboratory will be able to do more than a small subset of all proteins.